title: [Still's disease, adult-onset Still's disease (AOSD)].
authors.affiliation: Medizinische Poliklinik, Universitätsspital Zürich. urania.kolyvanos@usz.ch
authors.forename: U Kolyvanos
authors.initials: UK
authors.lastname: Naumann
authors.forename: Ch
authors.initials: Ch
authors.lastname: Nigg
authors.forename: L
authors.initials: L
authors.lastname: Käser
authors.forename: W
authors.initials: W
authors.lastname: Vetter
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D016706:Still's Disease, Adult-Onset / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous; D011241:Prednisone; D008727:Methotrexate